- The stock price of Applied UV Inc (NASDAQ: AUVI) increased from $8.50 to $10.47 (up 23.18%) today. This is why it happened.
The stock price of Applied UV Inc (NASDAQ: AUVI) – an infection control technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically – increased from $8.50 to $10.47 (up 23.18%) today. There was no direct news from the company so it appears that there was an external catalyst driving the price up.
Last month, the company had announced that the Chinese Patent office issued a notice granting Applied UV’s patent application for its core pathogen destroying device. SteriLumen — a wholly-owned subsidiary of Applied UV — owned eight issued patents in the United States; one issued patent in the European Union, one issued patent in China as well as several pending patent applications in the Gulf Cooperation Council (GCC), Japan, South Korea, Taiwan, and others as of April 7, 2021. And the issued patents and pending patent applications cover various aspects of the SteriLumen Disinfecting System.
Rumor has it that the patent in China was officially approved recently.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
